Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Rapoport

Showing results (81-90 of 179) with videos related to

Pageof 18
Sort By:
The Ocular Surface|January 12, 2023
Can Janus kinase inhibition improve ocular graft versus host disease?Seema Sajjan, Ellis Tibbs, Megan Utz, et al.
Blood Advances|December 7, 2020
Safety and efficacy of CAR T cells in a patient with lymphoma and a coexisting autoimmune neuropathyKhushali S Jhaveri, Ilana Schlam, Noa G Holtzman, et al.
Bone Marrow Transplantation|September 12, 2017
Durable remission with salvage decitabine and donor lymphocyte infusion (DLI) for relapsed early T-cell precursor ALLF El Chaer, N Holtzman, E Binder, et al.
Cancer|July 27, 2007
Neurotoxicity of bortezomib therapy in multiple myeloma: a single-center experience and review of the literatureAshraf Badros, Olga Goloubeva, Jay S Dalal, et al.
The American Journal of Surgical Pathology|March 10, 2026
Comprehensive Assessment of CD19 Immunohistochemical Staining in Classic Hodgkin LymphomaSarah R Helman, Fikru Merechi, Hanan Alharthy, et al.
Leukemia & Lymphoma|April 29, 2020
C-reactive protein: not always a reliable marker of ongoing cytokine release syndrome in CAR-T therapy following IL-6 blockadeJonathan Siglin, Ali Bukhari, Forat Lutfi, et al.
Journal Francais D'Ophtalmologie|December 3, 1998
[Benign intracranial hypertension. Retrospective study of 20 cases]H Merle, D Smadja, L Ayeboua, et al.
Annals of Hematology|October 8, 2013
Single center experience with total body irradiation and melphalan (TBI-MEL) myeloablative conditioning regimen for allogeneic stem cell transplantation (SCT) in patients with refractory hematologic malignanciesBhavana Bhatnagar, Aaron P Rapoport, Hong-Bin Fang, et al.
Bone Marrow Transplantation|May 11, 2004
High-dose cyclophosphamide with or without etoposide for mobilization of peripheral blood progenitor cells in patients with multiple myeloma: efficacy and toxicityI Gojo, C Guo, C Sarkodee-Adoo, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 23, 2011
Granulomatous amebic encephalitis: an under-recognized cause of infectious mortality after hematopoietic stem cell transplantationG Akpek, A Uslu, T Huebner, et al.
Pageof 18

Showing results (81-90 of 179) with videos related to

Sort By:
Pageof 18
The Ocular Surface|January 12, 2023
Can Janus kinase inhibition improve ocular graft versus host disease?Seema Sajjan, Ellis Tibbs, Megan Utz, et al.
Blood Advances|December 7, 2020
Safety and efficacy of CAR T cells in a patient with lymphoma and a coexisting autoimmune neuropathyKhushali S Jhaveri, Ilana Schlam, Noa G Holtzman, et al.
Bone Marrow Transplantation|September 12, 2017
Durable remission with salvage decitabine and donor lymphocyte infusion (DLI) for relapsed early T-cell precursor ALLF El Chaer, N Holtzman, E Binder, et al.
Cancer|July 27, 2007
Neurotoxicity of bortezomib therapy in multiple myeloma: a single-center experience and review of the literatureAshraf Badros, Olga Goloubeva, Jay S Dalal, et al.
The American Journal of Surgical Pathology|March 10, 2026
Comprehensive Assessment of CD19 Immunohistochemical Staining in Classic Hodgkin LymphomaSarah R Helman, Fikru Merechi, Hanan Alharthy, et al.
Leukemia & Lymphoma|April 29, 2020
C-reactive protein: not always a reliable marker of ongoing cytokine release syndrome in CAR-T therapy following IL-6 blockadeJonathan Siglin, Ali Bukhari, Forat Lutfi, et al.
Journal Francais D'Ophtalmologie|December 3, 1998
[Benign intracranial hypertension. Retrospective study of 20 cases]H Merle, D Smadja, L Ayeboua, et al.
Annals of Hematology|October 8, 2013
Single center experience with total body irradiation and melphalan (TBI-MEL) myeloablative conditioning regimen for allogeneic stem cell transplantation (SCT) in patients with refractory hematologic malignanciesBhavana Bhatnagar, Aaron P Rapoport, Hong-Bin Fang, et al.
Bone Marrow Transplantation|May 11, 2004
High-dose cyclophosphamide with or without etoposide for mobilization of peripheral blood progenitor cells in patients with multiple myeloma: efficacy and toxicityI Gojo, C Guo, C Sarkodee-Adoo, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|February 23, 2011
Granulomatous amebic encephalitis: an under-recognized cause of infectious mortality after hematopoietic stem cell transplantationG Akpek, A Uslu, T Huebner, et al.
Pageof 18